Article Details

Merck Completes Acquisition of Investigational Bispecific Antibody Therapy from Curon ...

Retrieved on: 2024-10-01 20:28:47

Tags for this article:

Click the tags to see associated articles and topics

Merck Completes Acquisition of Investigational Bispecific Antibody Therapy from Curon .... View article details on hiswai:

Excerpt

Merck announced that it has completed its acquisition of CN201, an investigational bispecific antibody, from Curon Biopharmaceutical. CN201 is ...

Article found on: www.pharmexec.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up